Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β

被引:22
作者
Burbelo, Peter D. [1 ]
Hirai, Hiroki [2 ]
Issa, Alexandra T. [1 ]
Kingman, Albert
Lernmark, Ake [3 ]
Ivarsson, Sten-A. [3 ]
Notkins, Abner L. [2 ]
Iadarola, Michael J. [1 ]
机构
[1] Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA
[2] Natl Inst Dent & Craniofacial Res, Expt Med Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD USA
[3] Malmo Univ Hosp, Dept Paediat, Malmo, Sweden
基金
美国国家卫生研究院;
关键词
AUTOANTIGENS; DISEASE;
D O I
10.2337/dc09-1938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare the sensitivity and specificity of luciferase immunoprecipitation (LIPS) with radioimmunoprecipitation (RIP) for the measurement of autoantibodies to the type 1 diabetes autoantigens glutamic acid decarboxylase 65 (GAD65) and insulinoma-associated protein (IA)-2 beta. RESEARCH DESIGN AND METHODS - Sera from 49 type 1 diabetic patients and 100 nondiabetic control subjects from Diabetes Antibody Standardization Program 2007 were used to screen for autoantibodies to GAD65. An additional 200 type 1 diabetic patients and 200 nondiabetic control subjects were used to validate the GAD65 results and screen for autoantibodies to IA-2 beta. RESULTS - LIPS showed equal sensitivity and specificity to RIP for detecting autoantibodies to GAD65 and IA-2 beta. Receiver-operating characteristic analysis revealed that the detection of autoantibodies to GAD65 and IA-2 beta by LIPS and RIP were not statistically different. CONCLUSIONS - The LIPS assay does not require the use of radioisotopes or in vitro transcription/translation and is a practical alternative at the clinical level for the RIP assay.
引用
收藏
页码:754 / 756
页数:3
相关论文
共 10 条
[1]   Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives [J].
Achenbach, P. ;
Bonifacio, E. ;
Williams, A. J. K. ;
Ziegler, A. G. ;
Gale, E. A. M. ;
Bingley, P. J. .
DIABETOLOGIA, 2008, 51 (03) :488-492
[2]   A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2 [J].
Burbelo, Peter D. ;
Hirai, Hiroki ;
Leahy, Hannah ;
Lernmark, Ake ;
Ivarsson, Sten A. ;
Iadarola, Michael J. ;
Notkins, Abner Louis .
DIABETES CARE, 2008, 31 (09) :1824-1826
[3]  
Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549
[4]   Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens [J].
Hirai, Hiroki ;
Miura, Junnosuke ;
Hu, Yafang ;
Larsson, Helena ;
Larsson, Karin ;
Lernmark, Ake ;
Ivarsson, Sten-A. ;
Wu, Tianxia ;
Kingman, Albert ;
Tzioufas, Athanasios G. ;
Notkins, Abner L. .
CLINICAL IMMUNOLOGY, 2008, 127 (03) :366-374
[5]   A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease [J].
Li, Marcella ;
Yu, Liping ;
Tiberti, Claudio ;
Bonamico, Margherita ;
Taki, Iman ;
Miao, Dongmei ;
Murray, Joseph A. ;
Rewers, Marian J. ;
Hoffenberg, Edward J. ;
Agardh, Daniel ;
Mueller, Patricia ;
Stern, Martin ;
Bonifacio, Ezio ;
Liu, Edwin .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (01) :154-163
[6]  
Li Q, 1997, P ASSOC AM PHYSICIAN, V109, P429
[7]   Previous exposure to measles, mumps, and rubella -: But not vaccination during adolescence -: Correlates to the prevalence of pancreatic and thyroid autoantibodies [J].
Lindberg, B ;
Ahlfors, K ;
Carlsson, A ;
Ericsson, UB ;
Landin-Olsson, M ;
Lernmark, Å ;
Ludvigsson, J ;
Sundkvist, G ;
Ivarsson, SA .
PEDIATRICS, 1999, 104 (01)
[9]   Autoimmune type 1 diabetes:: resolved and unresolved issues [J].
Notkins, AL ;
Lernmark, Å .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) :1247-1252
[10]   Diabetes Antibody Standardization Program:: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2 [J].
Torn, C. ;
Mueller, P. W. ;
Schlosser, M. ;
Bonifacio, E. ;
Bingley, P. J. .
DIABETOLOGIA, 2008, 51 (05) :846-852